Improving breast cancer screening through advanced risk models
Official title: Core A: Administration, Communication and Project Management
Funded at University of California, San Francisco · NIH-10935788 · Data updated 2026-11-12
This study is looking at ways to make breast cancer screening better by creating personalized risk models based on different types of breast cancer, so that women can get the most effective screenings for their specific needs.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 11, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $331,807 |
| NIH project number | 1P01CA281826-01A1 |
| Project ID | NIH-10935788 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at varying risk levels for breast cancer, particularly those with specific genetic or biological markers.
✕Less likely to help
Patients who do not have a risk of breast cancer or those who are not eligible for screening may not benefit from this research.
What this research studies
This research focuses on enhancing breast cancer screening by developing and implementing subtype-specific risk models. It aims to evaluate how these models can improve screening outcomes by analyzing data from large population cohorts, including imaging and genomic information. The project will also assess the long-term benefits and cost-effectiveness of these tailored screening recommendations. By ensuring effective communication and project management, the research seeks to integrate various scientific efforts and collaborations.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and personalized breast cancer screening, potentially improving early detection rates.
How similar studies have gone: Previous research has shown promise in using tailored risk models for breast cancer screening, indicating that this approach has potential for success.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Fiscalini, Allison Stover — University of California, San Francisco
- Study coordinator: Fiscalini, Allison Stover
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.